Blinatumomab is a bispecific CD19-directed CD3 T-cell engager. The Food and Drug Administration (FDA) has approved Blincyto ® (blinatumomab) for the treatment of adult and pediatric patients 1 month ...
Clinical trial data demonstrate that Cavhanza can be taken with or without food, offering patients greater administration convenience.
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Dr Radich is a ...
THOUSAND OAKS, Calif., June 14, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to ponatinib with chemotherapy for the treatment of adults with newly ...
Phase II trial of mini-hyper-CVD-inotuzumab (InO) followed by blinatumomab (blina) consolidation in patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). This is an ASCO Meeting ...
PHILADELPHIA (CBS) — A child's cancer diagnosis affects the entire family and those effects can be immense and in various forms. For the Taunk family, it means stress from the cancer and subsequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results